{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:31:09Z","timestamp":1786120269821,"version":"build-2736575974"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1111\/j.1524-4725.2011.02131.x","type":"journal-article","created":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T14:09:34Z","timestamp":1312207774000},"page":"1584-1589","source":"Crossref","is-referenced-by-count":15,"title":["Polyacrylamide Gel Injection for Treatment of Human Immunodeficiency Virus-Associated Facial Lipoatrophy: 18 Months Follow-Up"],"prefix":"10.1097","volume":"37","author":[{"given":"Raffaele","family":"Rauso","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Freda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Parlato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Gherardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianpaolo","family":"Tartaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210206","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMra041811","article-title":"Cardiovascular risk and bodyfat abnormalities in HIVinfected patients.","volume":"352","author":"Grinspoon","year":"2005","journal-title":"N Engl J Med"},{"key":"R2-4-20210206","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/108729102760330254","article-title":"Lipodystrophy syndrome and selfassessment of wellbeing and physical appearance in HIVpositive patients.","volume":"16","author":"Oette","year":"2002","journal-title":"AIDS Patient Care STDs"},{"key":"R3-4-20210206","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/sti.79.2.137","article-title":"A qualitative study of the psychosocial implications of lipodystrophy syndrome on HIV positive individuals.","volume":"4","author":"Power","year":"2003","journal-title":"Sex Transm Infect"},{"key":"R4-4-20210206","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1089\/apc.2005.19.577","article-title":"Lipodystrophyassociated symptoms and medication adherence in HIVAIDS.","volume":"19","author":"Corless","year":"2005","journal-title":"AIDS Patient Care STDs"},{"key":"R5-4-20210206","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1097\/00002030-200112070-00012","article-title":"Failure to maintain longterm adherence to highly active antiretroviral therapy: the role of lipodystrophy.","volume":"15","author":"Duran","year":"2001","journal-title":"AIDS"},{"key":"R6-4-20210206","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.bjps.2007.10.031","article-title":"Experience in the treatment of HIVassociated lipodystrophy.","volume":"61","author":"Nelson","year":"2008","journal-title":"J Plast Reconstr Surg"},{"key":"R7-4-20210206","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.PRS.0000128427.54445.63","article-title":"Treatment of facial fat atrophy related to treatment with protease inhibitor by autologous fat injection in patients with human immunodeficiency virus infection.","volume":"114","author":"SerraRenom","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R8-4-20210206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","article-title":"A systematic review of permanent and semipermanent dermal filler for HIVassociated lipoatrophy.","volume":"23","author":"Sturm","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"R9-4-20210206","first-page":"979","article-title":"HIVassociated facial lipoatrophy.","volume":"28","author":"James","year":"2002","journal-title":"Dermatol Surg"},{"key":"R10-4-20210206","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.2105\/AJPH.91.7.1060","article-title":"HIV in the United States at the turn of the century.","volume":"91","author":"Karon","year":"2001","journal-title":"Am J Public Health"},{"key":"R11-4-20210206","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1097\/01.prs.0000267341.14550.a7","article-title":"Surgical algorithm for management of HIV lipodystrophy.","volume":"120","author":"Davison","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R12-4-20210206","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1159\/000096193","article-title":"Surgery for foreign body reactions due to injectable fillers.","volume":"213","author":"Wolfram","year":"2006","journal-title":"Dermatology"},{"key":"R15-4-20210206","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0714.2004.00194.x","article-title":"Orofacial granulomas after injection of cosmetic fillers: histopathologic and clinical study of 11 cases.","volume":"33","author":"Lombardi","year":"2004","journal-title":"J Oral Pathol Med"},{"key":"R16-4-20210206","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/01.PRS.0000133425.22598.D0","article-title":"Biocompatibility and tissue interactions of a new filler material for medical use.","volume":"114","author":"Zarini","year":"2004","journal-title":"Plast Reconstr Surg"},{"key":"R17-4-20210206","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1097\/01.prs.0000254824.13065.3b","article-title":"The use of polyacrylamide gel in soft tissue augmentation: an experimental assessment.","volume":"119","author":"Bello","year":"2007","journal-title":"Plast Reconstr Surg"},{"key":"R18-4-20210206","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s00266-003-2119-x","article-title":"Experiences with a new nonbiodegradable hydrogel (Aquamid): a pilot study.","volume":"27","author":"de Cassia Novaes","year":"2003","journal-title":"Aesthetic Plast Surg"},{"key":"R19-4-20210206","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1097\/PRS.0b013e3181d18158","article-title":"A 5years assessment of safety and aesthetic results after facial softtissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients.","volume":"125","author":"Pallua","year":"2010","journal-title":"Plast Reconstr Surg"},{"key":"R20-4-20210206","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/01.PRS.0000056873.87165.5A","article-title":"Long term effects of polyacrylamide hydrogel (PAAG, InterfallContura SA) in human breast tissue.","volume":"111","author":"Christensen","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"R21-4-20210206","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00266-004-0113-6","article-title":"Adverse reaction to injectable soft tissue permanent fillers.","volume":"29","author":"Christensen","year":"2005","journal-title":"Aesthetic Plast Surg"},{"key":"R22-4-20210206","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1097\/01.prs.0000179349.14392.a4","article-title":"Efficacy and safety of polyacrylamide hydrogel for facial softtissue augmentation. Plast.","volume":"116","author":"von Buelow","year":"2005","journal-title":"Reconstr Surg"},{"key":"R23-4-20210206","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00266-003-3022-1","article-title":"Human histology and persistence of various injectable filler substances for soft tissue augmentation.","volume":"27","author":"Lemperle","year":"2003","journal-title":"Aesthetic Plast Surg"},{"key":"R24-4-20210206","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1097\/01.prs.0000298108.46379.15","article-title":"Polyacrylamide hydrogel injection in the management of human immunodeficiency virusrelated facial lipoatrophy: a 2 year clinical experience.","volume":"121","author":"De Santis","year":"2008","journal-title":"Plast Reconstr Surg"},{"key":"R25-4-20210206","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1089\/apc.2006.20.829","article-title":"Reconstructive treatment for antiretroviralassociated facial lipoatrophy: a prospective study comparing autologous fat and synthetic substances.","volume":"20","author":"Negredo","year":"2006","journal-title":"AIDS Patient Care STDs"},{"key":"R26-4-20210206","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1089\/apc.2008.0230","article-title":"A systematic review of permanent and semipermanent dermal fillers of HIVassociated facial lipoatrophy.","volume":"23","author":"Sturm","year":"2009","journal-title":"AIDS Patient Care STDs"},{"key":"R27-4-20210206","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/aid.2008.0230","article-title":"Fouryear safety with polyacrylamide hydrogel to correct antiretroviralrelated facial lipoatrophy.","volume":"25","author":"Negredo","year":"2009","journal-title":"AIDS Res Hum Retrov"},{"key":"R28-4-20210206","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1097\/00002030-200311210-00009","article-title":"Polylactic acid implants (NEW Fill) to correct facial lipoatrophy in HIVinfected patients: results of the open-label study VEGA.","volume":"17","author":"Valantin","year":"2003","journal-title":"AIDS"},{"key":"R29-4-20210206","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/QAI.0b013e318158bec9","article-title":"A randomized multicenter, openlabel study of polyLlactic acid for HIV1 faciual lipoatrophy.","volume":"46","author":"Carey","year":"2007","journal-title":"J Acquir Immune Defic Syndr"}],"container-title":["Dermatologic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00042728-201111000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:22:40Z","timestamp":1786047760000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00042728-201111000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1524-4725.2011.02131.x","relation":{},"ISSN":["1076-0512"],"issn-type":[{"value":"1076-0512","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}